These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 24726886

  • 21. In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.
    Kim KI, Park JH, Lee YJ, Lee TS, Park JJ, Song I, Nahm SS, Cheon GJ, Lim SM, Chung JK, Kang JH.
    J Gene Med; 2012 Aug; 14(8):513-20. PubMed ID: 22761128
    [Abstract] [Full Text] [Related]

  • 22. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.
    Lu SY, Sui YF, Li ZS, Pan CE, Ye J, Wang WY.
    World J Gastroenterol; 2003 Apr; 9(4):688-91. PubMed ID: 12679911
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M, Rodriguez-Madoz JR, Alzuguren P, Gomar C, Kramer MG, Kochanek S, Prieto J, Smerdou C, Qian C.
    Cancer Res; 2006 Feb 01; 66(3):1620-9. PubMed ID: 16452221
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
    Ohashi M, Kanai F, Tateishi K, Taniguchi H, Marignani PA, Yoshida Y, Shiratori Y, Hamada H, Omata M.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):529-35. PubMed ID: 11401492
    [Abstract] [Full Text] [Related]

  • 27. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
    Chen GG, Ho RL, Wong J, Lee KF, Lai PB.
    Eur J Surg Oncol; 2007 Sep 30; 33(7):882-6. PubMed ID: 17433605
    [Abstract] [Full Text] [Related]

  • 28. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S.
    Cancer Res; 1995 Jul 15; 55(14):3105-9. PubMed ID: 7541712
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy.
    Peng YF, Shi YH, Ding ZB, Zhou J, Qiu SJ, Hui B, Gu CY, Yang H, Liu WR, Fan J.
    PLoS One; 2013 Jul 15; 8(2):e53072. PubMed ID: 23468839
    [Abstract] [Full Text] [Related]

  • 31. An advanced strategy of enhanced specific gene expression for hepatocellular carcinoma.
    Takikawa H, Mafune K, Hamada H, Nettelbeck DM, Müller R, Makuuchi M, Kaminishi M.
    Int J Oncol; 2003 May 15; 22(5):1051-6. PubMed ID: 12684671
    [Abstract] [Full Text] [Related]

  • 32. Radioiodine gene therapy of hepatocellular carcinoma targeted human alpha fetoprotein.
    Jin YN, Chung HK, Kang JH, Lee YJ, Kimm KI, Kim YJ, Kim S, Chung JK.
    Cancer Biother Radiopharm; 2008 Oct 15; 23(5):551-60. PubMed ID: 18986218
    [Abstract] [Full Text] [Related]

  • 33. Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector.
    Kanai F.
    Mol Biotechnol; 2001 Jul 15; 18(3):243-50. PubMed ID: 11503518
    [Abstract] [Full Text] [Related]

  • 34. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.
    Li W, Li DM, Chen K, Chen Z, Zong Y, Yin H, Xu ZK, Zhu Y, Gong FR, Tao M.
    BMC Cancer; 2012 Nov 23; 12():547. PubMed ID: 23173703
    [Abstract] [Full Text] [Related]

  • 35. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma.
    Ren XW, Liang M, Meng X, Ye X, Ma H, Zhao Y, Guo J, Cai N, Chen HZ, Ye SL, Hu F.
    Cancer Gene Ther; 2006 Feb 23; 13(2):159-68. PubMed ID: 16082383
    [Abstract] [Full Text] [Related]

  • 36. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
    Takahashi M, Sato T, Sagawa T, Lu Y, Sato Y, Iyama S, Yamada Y, Fukaura J, Takahashi S, Miyanishi K, Yamashita T, Sasaki K, Kogawa K, Hamada H, Kato J, Niitsu Y.
    Mol Ther; 2002 May 23; 5(5 Pt 1):627-34. PubMed ID: 11991754
    [Abstract] [Full Text] [Related]

  • 37. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 23; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

  • 38. Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
    Yan C, Yang M, Li Z, Li S, Hu X, Fan D, Zhang Y, Wang J, Xiong D.
    Biomaterials; 2014 Mar 23; 35(9):3035-43. PubMed ID: 24406219
    [Abstract] [Full Text] [Related]

  • 39. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S, Nakatsukasa H, Higashi T, Ashida K, Nouso K, Ishizaki M, Hino N, Kobayashi Y, Uematsu S, Tsuji T.
    Hepatology; 1998 Feb 23; 27(2):599-607. PubMed ID: 9462663
    [Abstract] [Full Text] [Related]

  • 40. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
    Lam PY, Sia KC, Khong JH, De Geest B, Lim KS, Ho IA, Wang GY, Miao LV, Huynh H, Hui KM.
    Mol Ther; 2007 Jun 23; 15(6):1129-36. PubMed ID: 17426711
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.